Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Impaired AMPK control of alveolar epithelial cell metabolism promotes pulmonary fibrosis
Luis R. Rodríguez, Konstantinos-Dionysios Alysandratos, Jeremy Katzen, Aditi Murthy, Willy Roque Barboza, Yaniv Tomer, Sarah Bui, Rebeca Acín-Pérez, Anton Petcherski, Kasey Minakin, Paige Carson, Swati Iyer, Katrina Chavez, Charlotte H. Cooper, Apoorva Babu, Aaron I. Weiner, Andrew E. Vaughan, Zoltan Arany, Orian S. Shirihai, Darrell N. Kotton, Michael F. Beers
Luis R. Rodríguez, Konstantinos-Dionysios Alysandratos, Jeremy Katzen, Aditi Murthy, Willy Roque Barboza, Yaniv Tomer, Sarah Bui, Rebeca Acín-Pérez, Anton Petcherski, Kasey Minakin, Paige Carson, Swati Iyer, Katrina Chavez, Charlotte H. Cooper, Apoorva Babu, Aaron I. Weiner, Andrew E. Vaughan, Zoltan Arany, Orian S. Shirihai, Darrell N. Kotton, Michael F. Beers
View: Text | PDF
Research Article Metabolism Pulmonology

Impaired AMPK control of alveolar epithelial cell metabolism promotes pulmonary fibrosis

  • Text
  • PDF
Abstract

Alveolar epithelial type II (AT2) cell dysfunction is implicated in the pathogenesis of familial and sporadic idiopathic pulmonary fibrosis (IPF). We previously demonstrated that expression of an AT2 cell–exclusive disease-associated protein isoform (SP-CI73T) in murine and patient-specific induced pluripotent stem cell–derived (iPSC-derived) AT2 cells leads to a block in late macroautophagy and promotes time-dependent mitochondrial impairments; however, how a metabolically dysfunctional AT2 cell results in fibrosis remains elusive. Here, using murine and human iPSC-derived AT2 cell models expressing SP-CI73T, we characterize the molecular mechanisms governing alterations in AT2 cell metabolism that lead to increased glycolysis, decreased mitochondrial biogenesis, disrupted fatty acid oxidation, accumulation of impaired mitochondria, and diminished AT2 cell progenitor capacity manifesting as reduced AT2 cell self-renewal and accumulation of transitional epithelial cells. We identify deficient AMPK signaling as a critical component of AT2 cell dysfunction and demonstrate that targeting this druggable signaling hub can rescue the aberrant AT2 cell metabolic phenotype and mitigate lung fibrosis in vivo.

Authors

Luis R. Rodríguez, Konstantinos-Dionysios Alysandratos, Jeremy Katzen, Aditi Murthy, Willy Roque Barboza, Yaniv Tomer, Sarah Bui, Rebeca Acín-Pérez, Anton Petcherski, Kasey Minakin, Paige Carson, Swati Iyer, Katrina Chavez, Charlotte H. Cooper, Apoorva Babu, Aaron I. Weiner, Andrew E. Vaughan, Zoltan Arany, Orian S. Shirihai, Darrell N. Kotton, Michael F. Beers

×

Figure 6

AMPK agonism ameliorates the metabolic alterations observed in human iAT2I73T cells.

Options: View larger image (or click on image) Download as PowerPoint
AMPK agonism ameliorates the metabolic alterations observed in human iAT...
(A and B) Western blot and densitometry quantification (normalized to loading control and presented as FC over iAT2WT of serially cultured human iAT2 cells (135–182 days) demonstrate increased LDHA/B ratio and decreased p-AMPK/AMPK ratio in iAT2I73T (SFTPCI73T/tdTomato) cells compared with syngeneic corrected iAT2WT cells (SFTPCWT/tdTomato) (mean±SEM; n = 3 biological replicates). (C) Measurement of extracellular lactate by YSI biochemistry analyzer shows increased extracellular lactate in iAT2I73T compared with iAT2WT cells. This increase is significantly reduced by treatment with AICAR (1 mM, 24 hours) (mean±SEM; n = 3 biological replicates for AICAR-treated and n = 5 biological replicates for vehicle-treated, each with 2 experimental replicates of independent wells). (D) Unsupervised hierarchical clustering (Euclidean) heatmap of all DEGs (FDR < 0.05) in iAT2WT and iAT2I73T cells treated with AICAR treatment (1 mM, 24 hours) or vehicle (row-normalized z-score). Gene ontology (GO) analysis of each subgroup using Database for Annotation, Visualization, and Integrated Discovery (DAVID) identifies increased expression of genes associated with fatty acid and lipid synthesis and reduced expression of transcripts linked to cell cycle regulation and glycolysis after AICAR treatment. A subset of sample genes from each GO term is highlighted. (E and F) Western blot of AMPK pathway targets in iAT2I73T cell lysates verifies AMPK signaling activation and increased PGC1α phosphorylation following AICAR treatment (1 mM, 24 hours). Bar graphs depict densitometric quantification (mean±SEM; n = 3 biological replicates). (G) Respirometry quantification depicted as OCR/ECAR ratio in iAT2I73T and iAT2WT cells following AICAR (1 mM, 24 hours) treatment (mean±SEM; n = 3 biological replicates). *P < 0.05, **P < 0.005, ***P < 0.0005, by ordinary 1-way ANOVA (C and G) and 1-tailed unpaired t test (B and F).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts